Study of Recombinant Human Anti-PD-1 Monoclonal Antibody for Patients With Advanced Solid Tumors
Clinical trial NCT03713905 · COMPLETED
Trial details
- NCT number
- NCT03713905
- Sponsor
- Guangzhou Gloria Biosciences Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-01
- Primary completion
- 2022-02-28
- Enrollment
- 293
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.